ZEOX
Zeo ScientifiX, Inc.
OTC Markets OTCQB Healthcare United States
0,90 $US
+3.45% today
-66.34% YTD · -55.00% 1Y
0
Insider transactions
SEC Form 4 · AMF · BaFin — rolling 90 days
0
Hedge funds tracked
Latest available SEC 13F filings
41
/ 100
MIXED

Analysis Zeo ScientifiX, Inc. (ZEOX) — Kairos Score 41/100

Composite score aggregating 8 smart money dimensions: insiders (SEC/AMF/BaFin), hedge funds, politicians & gurus, price momentum, valuation, analyst consensus, financial health, earnings momentum. The higher the score, the more favorable the institutional signals consensus.

💡 Detailed breakdown (the 8 sub-scores) available in the Premium dashboard.

About Zeo ScientifiX, Inc.

Zeo ScientifiX, Inc., a clinical-stage biopharmaceutical company, focuses on the development of biological therapeutics for the treatment of degenerative diseases and regenerative medicines. Its lead product is Zofin, a product derived from amniotic fluid and manufactured to retain the naturally occurring extracellular vesicles, proteins, and cell secreted nanoparticles; Patient Pure X, a proprietary autologous biologic containing a nanoparticle fraction that is precipitated from a patient's own peripheral blood; and regenerative, anti-aging, and aesthetic medicine (RAAM) products and related services are used in the health care industry administered through doctors and clinics. It also provides SB 1768, which authorizes licensed physicians to administer certain stem cell therapies for use in the treatment of orthopaedic conditions, wound care, and pain management; HB 2246/SB 2586, Public Chapter 1016, which authorizes physicians to perform certain non-FDA-approved stem cell or regenerative medicine therapies; and HB 1275, Act 453, an establishing requirements for the use of certain human stem cell therapies. In addition, the company develops and distributes products that incorporate its proprietary ingredients for products to be used in topical aesthetic applications; and ZEO GROWX, ZEO HAIR GROW, and ZEO GROW BOOST, a serum comprised of hair growth stimulants for follicle stimulation. Further, it has a portfolio of proprietary products derived from ethically sourced birth tissue, including mesenchymal stem cells, stem cell and amniotic fluid derived exosomes, and Whartons Jelly matrix. The company was formerly known as Organicell Regenerative Medicine, Inc. and changed its name to Zeo ScientifiX, Inc. in February 2024. Zeo ScientifiX, Inc. was incorporated in 2011 and is based in Davie, Florida.

Key info

👔
CEO
Mr. Ian T. Bothwell
📍
HQ
3321 College Avenue, Suite 246, Davie, FL, 33314, United States
👥
Employees
33
💰
Market cap
7 053 696,00 $US
💸
Dividend yield
0.00%

🕴️ Insider activity (90 days)

0 transactions — 0 buys and 0 sales reported by Zeo ScientifiX, Inc. executives.

🏦 Hedge Funds

0 institutional funds report a position on ZEOX in their latest SEC quarterly filing.

📰 Recent news

15 recent articles on ZEOX.

🧠 What makes Kairos Insider

Beyond raw data, we aggregate and score every smart money signal to give you a unique view.

🧠

Kairos Score 0-100

8-dimension composite score: insiders · hedge funds · politicians · momentum · valuation · health · analysts · earnings.

🎯

Insider Clusters

Detection of clustered purchases or sales by several executives in the same stock.

🏦

13F Hedge Funds

Berkshire, Pershing Square, Tiger Global, Bridgewater and other reporting funds.

📈

ETF Rotations

NANC & GOP (Pelosi & Republicans), GURU (top hedge funds), ARK (Cathie Wood). See who enters and exits each week.

🔥

Google Trends

Spot marked changes in search interest around the stocks being followed.

📧

Email alerts

Create your watchlist and receive a brief of events affecting your tickers.

Companies in the same sector as Zeo ScientifiX, Inc.

Official sources · Public data · SEC EDGAR — Form 4 & 13F · AMF — Executive filings · BaFin — Directors' Dealings · Yahoo Finance · Alpha Vantage

🔓 Unlock the full analysis

This public page only shows a preview. The full analysis of ZEOX on the Kairos Insider dashboard includes:

✅ Full Kairos Score (8-axis radar + synthesis)
✅ History of all 0 insider transactions over 90 days
✅ All 0 detected institutional funds
✅ Thematic ETFs (ARK, BUZZ, NANC, GOP, JEPI…)
✅ Hot Stocks Google Trends
✅ Available history: AUM + rotations
✅ Fundamentals (P/E, PEG, EV/EBITDA, ROE…)
✅ Financial health (Altman Z, Piotroski F)
✅ Sector peers + recent earnings
See full analysis →
Analyze other tickers for free →

Free signup · Pro €19/month or €190/year